Background. Peritoneal transport rate, a major determinant of peritoneal dialysis (PD) patient survival, increases in most patients starting on PD, while in other patients peritoneal transport rate may decline. Although several factors may contribute to changes in peritoneal transport rate, inflammation is known to be associated with a high peritoneal transport rate, and residual renal function (RRF), which often declines after start of PD, may also be related to inflammation. Therefore, we hypothesized that changes in peritoneal transport rate during patients' first year on PD and declining RRF may be linked with inflammation. Methods. A total of 76 PD patients (40 males, mean age 56.8"14.1 years), who underwent two peritoneal equilibration tests at a mean of 0.4 months and 1 year after beginning PD, were included in the study. Based on the change in dialysate to plasma creatinine concentration ratio at 4-h dwell (DuP Cr) during first year on PD, the patients were divided into decreased or unchanged (group DUC; n s 22) and increased (group I; n s 54) groups. Results. Initially, group I had a lower proportion of high transporters and more often high serum C-reactive protein (sCRP, P10 mgul) and lower RRF compared with the DUC group. In group I, serum albumin and RRF decreased significantly and dialysate protein loss and glucose absorption increased significantly during the first year on PD. When patients were divided into two groups based on median change in RRF (1.9 mlumin), patients with a decrease in RRF )1.9 mlumin during first year on PD had a higher proportion of high sCRP, higher DuP Cr, and higher changes in DuP Cr compared to patients with a decrease in RRF O1.9 mlumin. Patients with elevated sCRP at one year included a higher proportion of patients who had high sCRP at the start of PD, higher increase in DuP Cr, lower serum albumin, lower RRF, and more decrease in RRF during first year on PD compared with patients having normal sCRP. RRF was inversely correlated with changes in DuP Cr during the first year on PD (rs À0.28, P s0.02). Multiple regression analysis revealed that the only factors affecting changes in DuP Cr were high sCRP and a low RRF. Conclusions. Our preliminary short-term study suggests that changes in peritoneal transport rate during patients' first year on PD may be linked with inflammation and declining residual renal function. Inflammation and residual renal function were identified as the only independent factors determining peritoneal transport rate during the first year on PD. It is possible that inflammation may cause both an increase in peritoneal transport rate and a decline in residual renal function, or that the decline in residual renal function and the increase in peritoneal transport rate may induce or aggravate inflammation. Further studies are needed to confirm these findings.
Introduction
It is now well appreciated that peritoneal transport rates in peritoneal dialysis (PD) patients have a major impact on clinical management. Since Twardowski et al. w1x developed the standardized peritoneal equilibration test (PET), PET has been widely accepted as a useful method to assess an individual's peritoneal transport rate and to determine the optimal dialysis prescription and dose of dialysis. More recently, it has been reported that peritoneal transport rate, classified by PET, is a major determinant of patient survival w2,3x.
However, peritoneal transport rate often changes after initiation of PD. Some studies have shown that in most patients peritoneal transport rate increases with time on PD w4,5x, while others have found that peritoneal transport rate may decrease in some patients with time w5x. Finally, after initial early changes in peritoneal transport rate, the membrane function often is stable for up to three years w5,6x. Although the reasons for these discrepant results are not clear, mediators produced in the inflammatory process due to infection or bioincompatible PD solutions have been suggested to be involved in the regulation of the peritoneal membrane permeability, possibly resulting in alteration of the peritoneal transport rate w7x. One may expect that exposure to components in the PD solution increases in patients with high peritoneal transport rate, both because of the increased permeability of the peritoneal membrane and the need for increased use of hypertonic solutions, especially in patients with low residual renal function (RRF).
Moreover, it has been suggested that changes in renal function may be related to production of inflammatory mediators w8x. The deterioration of renal function and appearance of uraemia can be associated with a significant increase in serum cytokine levels in chronic renal failure and dialysis patients w9x. The RRF declines after the start of dialysis in most endstage renal disease patients and this might result in less efficient removal of inflammatory mediators, which could perhaps affect both the peritoneum and the kidney. The serum C-reactive protein (CRP), which reflects the activity of pro-inflammatory cytokines, has been used as a marker of inflammation. A recent study reported that CRP was inversely related to renal function w8x. Based on these observations it is possible that changes in peritoneal transport rate might be linked to inflammation and changes in RRF.
To test this hypothesis, we investigated changes in peritoneal transport rate and possible factors determining changes in the peritoneal transport rate during first year on PD to elucidate a possible relationship between changes in peritoneal transport rate, inflammation, and RRF.
Subjects and methods

Patients and study design
Between September 1990 and June 1999, 117 patients who were treated with PD at the Home Dialysis Unit affiliated with the Department of Renal Medicine, Huddinge University Hospital, Stockholm, Sweden, underwent a PET study within one month of PD according to the routine in the department. Of the 117 patients, the 76 patients who underwent two PETs, nutritional assessments, and biochemical analyses both at -1 month and at )6 months, at a mean of 0.4"0.2 months (range: 0.1-1.0 month) and 12.0"3.1 months (range: 6.1-17.7 months) after beginning PD, were included in the study. Forty patients were male and their mean age was 56.8 years (range: 29-85 years). The causes of renal failure in the 76 patients were chronic glomerulonephritis (n s 26), diabetic nephropathy (n s 16), interstitial nephritis (n s 11), polycystic kidney disease (n s 8), and other diseases or unknown aetiology (n s 15).
Peritoneal equilibration test
The PET was performed as described by Twardowski et al. w1x . Briefly, a standard 4-h dwell period was used, using a 2.27% glucose concentration for a 2-l volume exchange. As glucose interferes with the assay for creatinine, the corrected value for creatinine was obtained by subtracting the glucose concentration multiplied by a correction factor (0.35) derived in our laboratory. The dialysate to plasma creatinine concentration ratio at 4-h of dwell (DuP Cr; mean DuP"1 SD) was used to classify the patients as having a high, high average, low average, or low peritoneal transport rate. Based on the changes (1-year value minus initial value) in DuP Cr during the first year on PD, the patients were divided into decreased or unchanged transport group (group DUC) and increased transport group (group I).
Residual renal function
RRF was estimated by calculating the average residual renal clearance of urea and creatinine. Based on the median value (1.9 mlumin) of changes in RRF during the first year on PD, the patients were divided into two groups: DRRF )1.9 mlumin and DRRF O1.9 mlumin.
Inflammation
Serum CRP was measured by using an immunonephelometric method for the assessment of inflammation. The patients were divided into two groups according to 1-year CRP levels (normal range: -10 mgul): CRP -10 mgul and CRP P10 mgul.
Body surface area
Body surface area was calculated using the Du Bois and Du Bois equation.
Biochemical analyses
A fasting venous blood sample was taken before the morning exchange. Blood chemistries were analysed by standard techniques. Serum albumin was determined by the bromcresol purple method.
Statistical analysis
Student's t-test for paired and unpaired measurement or Kruskal-Wallis test were used to compare the differences between initial PET and 1-year PET, and the differences in demographic and clinical variables between subgroups. Chisquare test or Fisher's exact test was used to compare the nominal variables between subgroups. Spearman's rank correlation was used to determine the correlation between residual renal function and changes in peritoneal transport rate. Multiple regression analysis was used to identify the factors determining the changes in DuP Cr. Data are presented as means"SD. The difference was considered significant when the P value was less than 0.05.
Results
Comparison of PET results between initial study and 1-year study in all patients
During the first year on PD, DuP Cr increased from 0.70"0.15 to 0.78"0.12 (P-0.001), D 4 uD 0 glucose decreased from 0.45"0.12 to 0.39"0.09 (P-0.005), and net ultrafiltration decreased from 339"321 ml to 263"213 ml (P-0.06).
PET results in group DUC and group I during the first year on PD During the first year on PD, 22 patients developed decreased or unchanged peritoneal transport rate (group DUC) and 54 patients developed increased transport rate (group I).
The PET results of the initial and 1-year studies in the two groups are shown in Table 1 . There were statistically significant differences in DuP Cr, D 4 uD 0 glucose, and net ultrafiltration between group DUC and group I. Group I had lower initial DuP Cr, higher initial D 4 uD 0 glucose, higher initial net ultrafiltration, higher 1-year DuP Cr, and lower 1-year D 4 uD 0 glucose compared with group DUC. During the first year on PD, in group DUC, DuP Cr decreased and D 4 uD 0 glucose and net ultrafiltration increased while in group I, DuP Cr increased and D 4 uD 0 glucose and net ultrafiltration decreased.
Comparisons of demographic variables between group DUC and group I
Demographic variables in the two groups are shown in Table 2 . There was a statistically significant difference in the proportion of initially high transporters between the two groups. Group I initially had a lower proportion of high transporters.
Comparison of clinical variables between group DUC and group I
Clinical variables in the two groups are shown in Table 3 . There were statistically significant differences in the proportion of patients with high serum CRP P10 mgul, changes in serum albumin, changes in dialysate protein loss, changes in glucose absorption, RRF, and changes in RRF between the two groups. More often at the 1-year test, the patients in group I had a high serum CRP and lower RRF compared with group DUC. In group I, serum albumin and RRF decreased significantly and dialysate protein loss and glucose absorption increased significantly during the first year on PD. *P-0.05, **P-0.01, and ***P-0.005 vs decreased or unchanged transport group. Comparison of clinical variables between patients with changes in RRF )1.9 mlumin and patients with changes in RRF O1.9 mlumin during the first year on PD Clinical variables in the two different changes in RRF groups during the first year on PD are shown in Table 4 . There were statistically significant differences in the proportion of patients with serum CRP P10 mgul, DuP Cr, and changes in DuP Cr. The patients who had changes in RRF )1.9 mlumin during first year on PD had more often at 1-year test a high serum CRP, higher DuP Cr, and higher changes in DuP Cr compared with patients who had changes in RRF O1.9 mlumin during the first year on PD. RRF at 1-year assessment was inversely correlated with changes in DuP Cr during the first year on PD (r sÀ0.28, P s0.02, ns 76) (Figure 1) .
Comparison of clinical variables between patients
with high CRP (P10 mgul) and patients with normal CRP (-10 mgul) Table 5 shows clinical variables according to serum CRP at 1-year on PD. More often at the initial test, patients with high CRP had a high serum CRP, higher changes in DuP Cr, lower serum albumin, lower RRF, and higher decline in RRF compared with patients having normal CRP.
Factors determining the changes in DuP Cr
Determinants of changes in DuP Cr among 12 variables, including age, time on PD, gender, the presence of diabetes, cardiovascular disease, peritonitis episode, serum CRP, serum albumin, dialysate glucose used, glucose absorption, RRF, and body surface area, are shown in Table 6 . Multiple regression analysis revealed that the factors determining the changes in DuP Cr were high serum CRP and a low RRF.
Discussion
This preliminary short-term study shows that during the initial year on PD, changes in peritoneal transport rate appeared to be linked to inflammation (high serum CRP) and changes in RRF. Patients with an increased peritoneal transport rate more often had high serum CRP, lower RRF, and significant decreases in serum albumin and RRF. Furthermore, the reduction in RRF was more marked in patients with signs of inflammation. Finally, high serum CRP and low RRF were the only identified predictors of increased peritoneal transport rates. It is well recognized that peritoneal transport rate changes with time on PD with some differences between the studies w4,5x. For example, Davies et al. w10x found a significant increase in DuP Cr after 6 months on PD compared to initial results obtained within 1 month of commencing PD. Struijk et al. w11x reported a significant decrease in solute transport after 5 months on PD compared with initial values obtained within 3 months after the start of PD. Blake et al. w5x observed an increase in 20% of patients, a decrease in 3% of patients, and unchanged peritoneal transport rate in 77% of patients between 6 and 12 months on PD. In the present study, peritoneal transport rate increased in the majority of patients during the first year on PD whereas peritoneal transport rate decreased or was unchanged in 29% of the patients. A difference between our study and previous studies is that we included only those patients who were investigated initially and after one year of PD.
Although the factors contributing to changes in peritoneal transport rate during the first year on PD are not clear, in the present study, changes in peritoneal transport rate were strongly correlated with high serum CRP, and patients with increased peritoneal transport rate had decreased serum albumin and increased dialysate protein loss. It is generally accepted that peritoneal transport rate depends on both effective peritoneal surface area and permeability w7x. Many of the mediators produced in the inflammatory process can affect microvascular permeability and vascular tone w12x. Of note is that serum CRP reflects the activity of pro-inflammatory cytokines w8x and serum CRP and dialysate albumin loss are main determinants of serum albumin w13x. Serum albumin is, perhaps erroneously, often used as a marker for nutrition in PD patients. In the present study, although the origin of inflammation at start of PD was not clear and DuP Cr was not different between two CRP groups, our finding of a strong relationship between changes in peritoneal transport rate and serum inflammatory markers suggests that a state of inflammation may affect changes in peritoneal transport rate during the first year of PD.
In addition to this relationship, our study reveals that changes in peritoneal transport rate were strongly correlated with RRF. Patients with an increased peritoneal transport rate had lower RRF as well as a more marked decline of RRF during the first year of PD. Similar findings have been described by Davies et al. w6x , who reported that solute transport was stable in patients with stable RRF, resulting in a lesser requirement of hypertonic glucose exchanges in these patients w6x. This may suggest that changes in peritoneal transport rate could be related to intraperitoneal glucose or other components in the dialysis fluid. In the present study, we found no significant relationship between changes in peritoneal transport rate, amount of dialysate glucose used, and glucose absorption amount. In the patients with changes in RRF )1.9 ml, three patients used icodextrin solution and seven patients were treated with APD whereas in the patients with changes in RRF O1.9 ml, five patients were also treated with APD. This may explain why there was no major difference in the amount of dialysate glucose used and glucose absorption amount between the two groups.
On the other hand, there may also be an association between renal function and inflammatory mediators w14,15x. Brockhaus et al. w14x found that in uraemic non-dialysed patients, plasma levels of soluble tumour necrosis factor (TNF) receptors increased progressively with declining renal function. Herbelin et al. w15x reported that plasma interleukin (IL)-6 activity was significantly increased in patients with chronic renal failure compared to its level in normal individuals. This suggests that renal failure per se may contribute to the inflammatory response with elevated serum levels of pro-inflammatory cytokines. Indeed, reduced renal function may affect both TNF w16x and IL-1 w17x clearance in nephrectomized rats. The importance of the kidney in cytokine handling is further underscored by Hession et al. w18x who demonstrated that the Tamm-Horsfall glycoprotein might function as a unique renal regulatory glycoprotein that regulates the activity of potent cytokines, such as IL-1 and TNF. Therefore, our finding of a negative correlation between changes in peritoneal transport rate and RRF may suggest that a reduction in renal function may aggravate an inflammatory state due to decreased renal clearance of cytokines w14,15x and that this may increase the peritoneal transport rate w12x.
The association between reduction in RRF and high serum CRP in the present study is in agreement with some previous reports w19,20x, indicating a detrimental role of inflammation on RRF. Shin et al. w19x reported that peritonitis rate was an independent risk factor for the declining RRF, resulting in release of cytokines during the inflammatory process. Rottembourg w21x proposed that a rapid decline of RRF in HD patients may be related to nephrotoxic effects of the inflammatory mediators generated by extracorporeal circulation. In a previous study w22x, we found that there were significant inverse correlations between serum hyaluronan concentration and RRF, and between serum TNF-a and RRF. On the other hand, it is also possible that fluid overload, resulting from reduction in RRF, may cause inflammation w23x.
In contrast to previous research w6x, in the present study, peritoneal transport rate was not related with body surface area. Davies et al. w6x reported that at 6 months of PD there was a strong correlation between DuP Cr and body surface area. However, in the present study, there was no difference in body surface area between the two groups and no correlation between body surface area and changes in peritoneal transport rate.
In conclusion, our preliminary short-term study suggests that peritoneal transport rate during patients' first year on PD may be linked with inflammation and declining RRF. In fact, inflammation and RRF were identified as the only independent factors determining peritoneal transport rate during the first year on PD. It is possible that inflammation may cause both an increase in peritoneal transport rate and a decline in RRF, or that the decline in RRF further aggravates inflammation due to less efficient removal of cytokines. On the other hand, it cannot be ruled out that the decline in RRF and the increase in peritoneal transport rate may result in changes (fluid overload or increased use of hypertonic glucose solutions?) that might aggravate inflammation. Further long-term prospective studies are needed in this area.
